alexa CD56+ Muscle Derived Cells but Not Retinal NG2+ Perivascular Cells of Nonhuman Primates are Myogenic after Intramuscular Transplantation in Immunodeficient Mice | Open Access Journals
ISSN: 2157-7633
Journal of Stem Cell Research & Therapy
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

CD56+ Muscle Derived Cells but Not Retinal NG2+ Perivascular Cells of Nonhuman Primates are Myogenic after Intramuscular Transplantation in Immunodeficient Mice

Daniel Skuk* and Jacques P Tremblay

Axe Neurosciences, Research Center of the CHU de Quebec - CHUL, Quebec, QC, Canada

*Corresponding Author:
Daniel Skuk
Axe Neurosciences (P-09300), CHUL, 2705 Boulevard Laurier
Québec (QC), G1V 4G2, Canada
Tel: +1(418)654-2186
Fax: +1(418)654-2207
E-mail: [email protected]

Received date: December 19, 2016; Accepted date: February 17, 2017; Published date: February 23, 2017

Citation: Skuk D, Tremblay JP (2017) CD56+ Muscle Derived Cells but Not Retinal NG2+ Perivascular Cells of Nonhuman Primates are Myogenic after Intramuscular Transplantation in Immunodeficient Mice. J Stem Cell Res Ther 7:377. doi: 10.4172/2157-7633.1000377

Copyright: © 2017 Skuk D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Stem Cell Research & Therapy

Abstract

Some reports attributed to pericytes and other perivascular cells (PCs), regardless of their origin, optimal properties for cell therapy in myology. The retina is an ideal tissue to obtain pericytes and one study reported that PCs from the mouse retina were myogenic in vitro. Given the importance of nonhuman primates (NHPs) for translational research, we compared the in vivo myogenicity of NHP retinal PCs and satellite cell derived myoblasts (SCDMs) by transplantation in immunodeficient mice. We used a protocol to culture retinal pericytes of large mammals with macaque retinas. By flow cytometry, 76%-78% of the cultured cells were NG2+. CD56+ SCDMs from another macaque were proliferated in vitro. Both Tibialis anterior muscles of 4 SCID mice were injected with 1x106 cells in saline (SCDMs in the right muscles and PCs in the left), using cardiotoxin to induce muscle regeneration. They were sampled 1 month later and analyzed by histology. In SCDM-grafted muscles, NHP nuclei were abundant, in large regions with numerous NHP-derived myofibers, and some of them were Pax7+. PC-grafted muscles showed no muscle regeneration, have few NHP nuclei in small regions devoid of myofibers, and no NHP-myofibers or Pax7+ NHP nuclei were observed. Therefore, NHP SCDMs, but not retinal NG2+ PCs, regenerated muscle in vivo in immunodeficient mice.

Commentary

Cancer is characterized by tissue invasion leading to destruction, inflammation, irritation, obstructions and compressions. All these causes of pain may be present in varying degrees in all stages. The pain management therefore depends on the management of cancer and vice versa.

The tissue destruction is the rule in cancers of solid organs and bones, in primitive or metastatic circumstances. Liver cancers reach large dimensions, cause destruction, necrosis, inflammation, bleeding and compression. Pain is typically multifactorial. The management of this pain uses different levels of treatment from paracetamol to morphine derivatives and morphine [1]. Specific treatments involved in the control of pain indirectly during disease control or directly in the control of mainly secondary lesions. This is the case of radiotherapy for brain metastases. The diagnosis of metastasis is made by CT or MRI front of cranial hypertension syndrome. The effects of radiation are tumoricidal, anti-inflammatory, decongestant, but also for consolidation and neurological decompression. Its analgesic efficacy is very important. The use of an intrathecal pump-delivered infusion in selected patients should be a complementary option [2].

Bone tumors, secondary more often than primary, indicative of cancers because of the pain offer a wider choice of treatment. Even if at this stage healing is impossible. The treatment is based on non-specific tools such as analgesics, bisphosphonates, cementoplasty and physiotherapy but also specific tools such as radiotherapy. Zoledronic acid and denosumab remain a safe and efficient choice in aggressive non metastatic post-menopausal breast cancer patients and for bone metastatic patients [3]. Radiotherapy plays a fundamental role with remarkable analgesic efficacy in pain associated with bone metastasis in general and in particular in spinal metastases for 30 to 80% of patients [4]. In this field new therapeutic findings as Strontium-89 are very promising in pain control particularly in resistant specific treatment such as castration in prostate cancer [5].

Inflammatory cancer is a common condition. Cancer has the ability to induce inflammation by genetic way, infection and tumor progression. Inflammatory breast cancer and obstructive or ulcerative cancers are good illustrations. Chemotherapy, hormone therapy or targeted therapies are at the forefront of the treatment of pain. Surgery by lifting obstacles and removing lesions plays an indirect role [6].

Pain can be specific to the organ due to its structure, operation, anatomical position and innervation [7]. Pain evokes the diagnosis. Pancreatic cancer is a particular example. The solar type of pain is typical. The treatment for this pain is difficult. Opioids are ineffective and surgery is limited by the late discovery of the tumor, the anatomic position and depth of the organ. Chemotherapy and chemo radiation therapy are not effective [8]. Surgical and CT guided block by alcohol appliance or splanchnic neurotomy in the case of pancreatic cancer and neurotomy and neurostimulation in other cases often remains last resorts [9].

Specific cancer treatments such as surgery, radiation therapy and medical treatments offer considerable benefits in the treatment of cancer pain. Depending on the type of cancer the combination with analgesics is done differently and at different levels. Their action is essential in the range of therapeutic choices.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 1117
  • [From(publication date):
    February-2017 - Nov 19, 2017]
  • Breakdown by view type
  • HTML page views : 1060
  • PDF downloads : 57
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

materialsci[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords